You have been chosen to receive this valuable information.
 
A SPECIAL
ANNOUNCEMENT FROM:
   LCGC Logo  
Advertisement
Patient-centered drug development has become a compelling new way forward because it enables us to overcome many of the barriers to participation. IQVIA™ Virtual Trials leverage technology, clinical expertise and connectivity to improve the pathway to the patient and accelerate study performance.
 
THE PATIENTS ARE OUT THERE WE HELP YOU ENGAGE THEM.
Studies that let patients participate from their homes can make all the difference in patient engagement and retention. IQVIA™ Virtual Trials surround the patient with a support system including smart, connected devices, remote-monitoring systems, a virtual investigator network and local healthcare providers. This helps motivate them not only to enter a study, but also stay engaged to completion.
 
See more ways we’re modernizing R&D
 
Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Pharmaceutical Technology Europe, a UBM publication. You are on the mailing list as %%emailaddress%%.